Left ventricular wall thickness \> 5 mm at the target site(s) for cell injection, confirmed by Contrast Echo within 4 weeks prior to enrollment, and free of thrombus
You may not be if
Vascular anatomy and/or peripheral artery disease that prevents or impedes cardiac catheterization
Aortic or mitral valve disease where valve replacement is indicated
Presence of mechanical aortic or mitral valves
Presence of aortic dissection
Planned staged treatment of CAD or other therapeutic intervention on the heart within the subsequent 3 months
TIA or stroke within 30 days prior to the procedure
ICD placement or ablation therapy within 30 days prior to the procedure
Acute coronary syndrome (ACS) or a myocardial infarction in the 30 days prior to the procedure
Revascularization within 30 days prior to intramyocardial injection of ADRCs
Pregnant or lactating status. Pregnancy as determined by a positive pregnancy test at screening or baseline.
Clareo Health | Cardiac REgistry of Celution Device for the Processing of Adipose-derived Regenerative Cells
